BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 22919683)

  • 1. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis.
    Palframan SL; Kwok T; Gabriel K
    Front Cell Infect Microbiol; 2012; 2():92. PubMed ID: 22919683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both the p33 and p55 subunits of the Helicobacter pylori VacA toxin are targeted to mammalian mitochondria.
    Foo JH; Culvenor JG; Ferrero RL; Kwok T; Lithgow T; Gabriel K
    J Mol Biol; 2010 Sep; 401(5):792-8. PubMed ID: 20615415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of the p33 and p55 domains of the Helicobacter pylori vacuolating cytotoxin.
    Torres VJ; Ivie SE; McClain MS; Cover TL
    J Biol Chem; 2005 Jun; 280(22):21107-14. PubMed ID: 15817461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vacuolating cytotoxin A (VacA) - A multi-talented pore-forming toxin from Helicobacter pylori.
    Junaid M; Linn AK; Javadi MB; Al-Gubare S; Ali N; Katzenmeier G
    Toxicon; 2016 Aug; 118():27-35. PubMed ID: 27105670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of a beta-helical region in the p55 domain of Helicobacter pylori vacuolating toxin.
    Ivie SE; McClain MS; Algood HM; Lacy DB; Cover TL
    BMC Microbiol; 2010 Feb; 10():60. PubMed ID: 20178613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. the versatility of the Helicobacter pylori vacuolating cytotoxin vacA in signal transduction and molecular crosstalk.
    Backert S; Tegtmeyer N
    Toxins (Basel); 2010 Jan; 2(1):69-92. PubMed ID: 22069547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative Products of Curcumin Rather Than Curcumin Bind to
    Chaturvedi M; Mishra M; Pandey A; Gupta J; Pandey J; Gupta S; Malik MZ; Somvanshi P; Chaturvedi R
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling the host environment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA).
    Kim IJ; Blanke SR
    Front Cell Infect Microbiol; 2012; 2():37. PubMed ID: 22919629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic actions of Helicobacter pylori vacuolating cytotoxin, VacA.
    Isomoto H; Moss J; Hirayama T
    Tohoku J Exp Med; 2010 Jan; 220(1):3-14. PubMed ID: 20046046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural organization of membrane-inserted hexamers formed by Helicobacter pylori VacA toxin.
    Pyburn TM; Foegeding NJ; González-Rivera C; McDonald NA; Gould KL; Cover TL; Ohi MD
    Mol Microbiol; 2016 Oct; 102(1):22-36. PubMed ID: 27309820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of Raft Partitioning of the Helicobacter pylori Pore-Forming Toxin VacA.
    Raghunathan K; Foegeding NJ; Campbell AM; Cover TL; Ohi MD; Kenworthy AK
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29531133
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting of Helicobacter pylori VacA to mitochondria.
    Galmiche A; Rassow J
    Gut Microbes; 2010; 1(6):392-5. PubMed ID: 21468222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori VacA, a distinct toxin exerts diverse functionalities in numerous cells: An overview.
    Chauhan N; Tay ACY; Marshall BJ; Jain U
    Helicobacter; 2019 Feb; 24(1):e12544. PubMed ID: 30324717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random mutagenesis of Helicobacter pylori vacA to identify amino acids essential for vacuolating cytotoxic activity.
    McClain MS; Czajkowsky DM; Torres VJ; Szabo G; Shao Z; Cover TL
    Infect Immun; 2006 Nov; 74(11):6188-95. PubMed ID: 16954403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between vacA Types and Development of Gastroduodenal Diseases.
    Thi Huyen Trang T; Thanh Binh T; Yamaoka Y
    Toxins (Basel); 2016 Jun; 8(6):. PubMed ID: 27294955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryo-EM Analysis Reveals Structural Basis of Helicobacter pylori VacA Toxin Oligomerization.
    Su M; Erwin AL; Campbell AM; Pyburn TM; Salay LE; Hanks JL; Lacy DB; Akey DL; Cover TL; Ohi MD
    J Mol Biol; 2019 May; 431(10):1956-1965. PubMed ID: 30954575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview of Helicobacter pylori VacA Toxin Biology.
    Foegeding NJ; Caston RR; McClain MS; Ohi MD; Cover TL
    Toxins (Basel); 2016 Jun; 8(6):. PubMed ID: 27271669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. There Are No Insurmountable Barriers: Passage of the
    Jarzab M; Skorko-Glonek J
    Membranes (Basel); 2023 Dec; 14(1):. PubMed ID: 38248700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain.
    González-Rivera C; Campbell AM; Rutherford SA; Pyburn TM; Foegeding NJ; Barke TL; Spiller BW; McClain MS; Ohi MD; Lacy DB; Cover TL
    Infect Immun; 2016 Sep; 84(9):2662-70. PubMed ID: 27382020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection.
    Salama NR; Otto G; Tompkins L; Falkow S
    Infect Immun; 2001 Feb; 69(2):730-6. PubMed ID: 11159961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.